Read it: https://academic.oup.com/jid/issue/232/Supplement_3
Articles from the JID Supplement: Advances in Influenza Therapeutics
- S169 – Introduction and Update: Advances in Influenza Therapeutics
Frederick G. Hayden, Richard J. Whitley
https://academic.oup.com/jid/article/232/Supplement_3/S169/7918883 - S177 – Use of Influenza Antivirals in Pandemic Response
Maria Zambon, Puja Myles, Norio Sugaya
https://academic.oup.com/jid/article/232/Supplement_3/S177/7918902 - S191 – Antivirals for Novel Influenza A Virus Infections
Timothy M. Uyeki, Jessica A. Belser
https://academic.oup.com/jid/article/232/Supplement_3/S191/7918923 - S210 – Evolution of WHO Influenza Antiviral Stockpile: Rapid Access and Use in Low- and Middle-Income Countries for Pandemic Preparedness and Response
Nahoko Shindo, Anne Huvos, Tim Nguyen
https://academic.oup.com/jid/article/232/Supplement_3/S210/7918934 - S215 – Use of Influenza Antivirals to Prevent Transmission
Benjamin J. Cowling, Yun Lin, Hideyuki Ikematsu
https://academic.oup.com/jid/article/232/Supplement_3/S215/7918949 - S227 – New Developments in Influenza Polymerase Inhibitors
Jingya Li, Yang Jin, Yeming Wang, Lianhan Shang, Bin Cao
https://academic.oup.com/jid/article/232/Supplement_3/S227/7918959 - S243 – Influenza Antivirals for Prevention and Treatment in Immunocompromised People
Madeleine R. Heldman, Michael J. Boeckh, Michael G. Ison
https://academic.oup.com/jid/article/232/Supplement_3/S243/7918975 - S254 – Platform Trials to Assess Therapeutics in Patients Hospitalized with Influenza
Alicia A. C. Waite, Leon Peto, Anthony C. Gordon, Peter Horby
https://academic.oup.com/jid/article/232/Supplement_3/S254/7918988 - S262 – Host Immunomodulatory Interventions in Severe Influenza
David S. C. Hui, Ken K. P. Chan
https://academic.oup.com/jid/article/232/Supplement_3/S262/7919004 - S273 – Laboratory Methods for Monitoring Influenza Antiviral Resistance
Emi Takashita, Cameron R. Wolfe, Jeremy C. Jones
https://academic.oup.com/jid/article/232/Supplement_3/S273/7919015 - S286 – Influenza Antiviral Pharmacokinetic–Pharmacodynamic Relationships in Pregnancy, Infancy, and Early Childhood
Lindsey E. Hastings, Edward P. Acosta, David W. Kimberlin
https://academic.oup.com/jid/article/232/Supplement_3/S286/7919025 - S299 – Modelling Influenza Antiviral Strategies: Reducing Burden and Preventing Resistance
Remy Pasco, Frederick G. Hayden, Lauren Ancel Meyers
https://academic.oup.com/jid/article/232/Supplement_3/S299/7919040 - S309 – Optimizing Antiviral Stockpiles for Pandemic Response: A Strategic Framework
Rick A. Bright
https://academic.oup.com/jid/article/232/Supplement_3/S309/7919054 - S314 – Point-of-Care and Home Use Influenza Diagnostics for Advancing Therapeutic and Public Health Strategies
Gregory L. Damhorst, Wilbur A. Lam
https://academic.oup.com/jid/article/232/Supplement_3/S314/7919064 - S327 – Improving Access to Influenza Testing and Treatment: Is it Time for Over-the-Counter Oseltamivir?
Kuyeun Lee, Andrew T. Pavia, Janet A. Englund
https://academic.oup.com/jid/article/232/Supplement_3/S327/7919072 - S333 – The Care Continuum of Patients With Influenza in the Post–COVID-19 Era: A Position Paper
Stamatis Karakonstantis et al.
https://academic.oup.com/jid/article/232/Supplement_3/S333/7919085 - S347 – Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza
John H. Beigel, David Oldach
https://academic.oup.com/jid/article/232/Supplement_3/S347/7919097